PDCD4 and myalgic encephalomeyelitis/chronic fatigue syndrome: Moreover, miR-21 is found to be upregulated in patients with chronic fatigue syndrome (CFS) and facilitates inflammatory responses by targeting PDCD4 (Bjersing et al., 2015).